Government Trades

Overview
Securities
Members
States
Chambers
Committees
Parties

SpringWorks Therapeutics Inc

(NASDAQ:SWTX)
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

top performing SWTX trades

Chris Jacobs headshot
Chris Jacobs
House (R-NY)
67.00%
Josh Gottheimer headshot
Josh Gottheimer
House (D-NJ)
24.70%
-14.00%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent SpringWorks Therapeutics trades made by congress members.
$1K - $15KstockPurchaseFeb 11, 2025Jan 29, 2025
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseAug 15, 2024Jul 19, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockSaleJul 09, 2024Jun 18, 2024
House
Josh GottheimerHouse (D-NJ)
$1K - $15KstockPurchaseJun 08, 2024May 09, 2024
House
Chris JacobsHouse (R-NY)
$1K - $15KstockPurchaseJan 20, 2023Dec 12, 2022
House